Why do some people (specially those with diffuse balding) experience more regrowth just with DHT blockers?
    Chat 9/8/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Microneedling →

    technique to create small wounds in skin to activate collagen production and hair growth

    At a glance
    In this general discussion post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg once a day
    💊 Minoxidil (oral) 5mg once a day 5 months
    💧 Dermarolling (topical) 1.5mm every 2 weeks 5 months
    the tone is 😐 neutral with some regrowth results.

    Other terms

    Diffuse thinners often experience more hair regrowth with DHT blockers like finasteride, possibly due to less DHT sensitivity and the presence of miniaturized, not completely bald, follicles. However, regrowth varies widely among individuals, influenced by factors like genetics, the stage of hair loss, and treatment methods such as minoxidil, microneedling, and dermarolling.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Fundamentals

      research Fundamentals

      November 2018 in “Springer eBooks”
      Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.
      Androgen Effects on the Skin

      research Androgen effects on the skin

      July 2015 in “Cambridge University Press eBooks”
      Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.
      Male Androgenetic Alopecia

      research Male androgenetic alopecia

      54 citations , July 2002 in “Clinical and Experimental Dermatology”
      This article provides a critical overview of recent discoveries in the genetics and molecular processes involved in androgenetic alopecia, focusing on its polygenic basis and DHT dependency, but reports no new clinical results.
      Idiopathic Hirsutism: Androgen Role and Treatment Options

      research Idiopathic Hirsutism*

      47 citations , August 2000 in “Endocrine Reviews”
      This review discusses idiopathic hirsutism, potential underlying mechanisms, and various therapeutic approaches without providing new clinical results, and emphasizes the need for further research on well-defined patient groups.